NCT06167967View on ClinicalTrials.gov

Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

990

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions
Colorectal Cancer
Interventions
DIAGNOSTIC_TEST

ctDNA methylation

A blood-based circulating tumor DNA methylation assay that uses 6 different methylation markers, SEPT9 region1, SEPT9 region2, BCAT1, IKZF1, BCAN and VAV3.

DIAGNOSTIC_TEST

standard treatment

This group was treated according to standard procedure

Trial Locations (1)

310016

RECRUITING

Sir Run Run Shao hospital, Hanzhou

All Listed Sponsors
lead

Sir Run Run Shaw Hospital

OTHER